Advertisement

 

 

ABCB1 gene polymorphism associated with clinical factors can predict drug-resistant tuberculosis.

ABCB1 gene polymorphism associated with clinical factors can predict drug-resistant tuberculosis.
Author Information (click to view)

Pontual Y, Pacheco VSS, Monteiro SP, Quintana MSB, Costa MJM, Rolla VC, de Castro L,


Pontual Y, Pacheco VSS, Monteiro SP, Quintana MSB, Costa MJM, Rolla VC, de Castro L, (click to view)

Pontual Y, Pacheco VSS, Monteiro SP, Quintana MSB, Costa MJM, Rolla VC, de Castro L,

Advertisement

Clinical science (London, England : 1979) 2017 07 05131(15) 1831-1840 doi 10.1042/CS20170277

Abstract

Polymorphism in the ABCB1 gene encoding P-glycoprotein, a transmembrane drug efflux pump, contributes to drug resistance and has been widely studied. However, their association with rifampicin and ethambutol resistance in tuberculosis (TB) patients is still unclear. Genotype/allele/haplotype frequencies in c.1236C > T (rs1128503), c.2677G > T/A (rs2032582), and c.3435C > T (rs1045642) were obtained from 218 patients. Of these, 80 patients with rifampicin and/or ethambutol resistance were selected as the case group and 138 patients were selected for the control group through the results of their culture and drug-sensitive tests. Patients aged <18 years and HIV-positive serologic tests were excluded. ABCB1 polymorphisms were determined using a PCR direct-sequencing approach, and restriction fragment length polymorphism (RFLP). A nomogram was constructed to simulate a combined prediction of the probability of anti-TB drug resistance, with factors including genotype c.1236C > T (rs1128503) (P=0.02), clinical form (P=0.03), previous treatment (P=0.01), and skin color (P=0.03), contributing up to 90% chance of developing anti-TB drug resistance. Considering genotype analyses, CT (rs1128503) demonstrated an increased chance of anti-TB drug resistance (odds ratio (OR): 2.34, P=0.02), while the analyses for ethambutol resistance revealed an association with a rare A allele (rs2032582) (OR: 12.91, P=0.01), the haplotype TTC (OR: 5.83, P=0.05), and any haplotype containing the rare A allele (OR: 7.17, P=0.04). ABCB1 gene polymorphisms in association with others risk factors contribute to anti-TB drug resistance, mainly ethambutol. The use of the nomogram described in the present study could contribute to clinical decision-making prior to starting TB treatment.

Submit a Comment

Your email address will not be published. Required fields are marked *

fifteen − 7 =

[ HIDE/SHOW ]